Literature DB >> 33520867

The effects of L-carnitine supplementation on indicators of inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials.

Hadis Fathizadeh1, Alireza Milajerdi2,3, Željko Reiner4, Elaheh Amirani5, Zatollah Asemi5, Mohammad Ali Mansournia6, Jamal Hallajzadeh7.   

Abstract

OBJECTIVE: Several trials investigated the efficacy of L-carnitine administration on markers of inflammation and indicators of oxidative stress; however, their findings are controversial. The aim of this study was to conduct a comprehensive meta-analysis and a critical review, which would analyze all randomized controlled trials (RCTs) in order to determine the effects of L-carnitine supplementation on inflammatory markers and oxidative stress.
METHODS: An electronic search was performed using Scopus, Cochrane Library, PubMed, Google scholar and Web of Science databases on publications from 1990 up to May 2020. Human RCTs conducted in healthy subjects or participants with certain disorders which investigating the efficacy of L-carnitine supplementation compared to control (placebo, usual treatment or no intervention) on inflammation and oxidative markers were included. Data were pooled applying a random-effects model and as the overall effect size, weighted mean difference (WMD) was presented. Between heterogeneity among studies was computed using Cochran's Q test and I-square (I2). Quality of studies assessed using the Jadad scale. Dose-response analysis was measured using meta-regression. The funnel plot, as well as the Egger's regression test was applied to determine the publication bias.
RESULTS: 44 trials (reported 49 effect sizes for different outcomes of interest) met the inclusion criteria for this meta-analysis. According to the findings, L-carnitine supplementation resulted in a significant reduction in C-reactive protein (CRP) (WMD: -0.10; 95% CI: -0.14, -0.06), interleukin 6 (IL-6) (WMD: -1.87; 95% CI: -2.80, -0.95), tumor necrosis factor-α (TNF-α) levels (WMD: -1.43; 95% CI: -2.03, -0.84), and malondialdehyde (MDA) (WMD: -0.47; 95% CI: -0.76, -0.18) levels, while there was a significant increase in superoxide dismutase (SOD) (WMD: 2.14; 95% CI: 1.02, 3.25). However, no significant effects of L-carnitine on glutathione peroxidase (GPx) (WMD: 0.02; 95% CI: -0.01, 0.05) and total antioxidant capacity (TAC) (WMD: 0.14; 95% CI: -0.05, 0.33) were found.
CONCLUSIONS: L-carnitine supplementation was associated with lowering of CRP, IL-6, TNF-α, and MDA, and increasing SOD levels, but did not affect other inflammatory and oxidative stress biomarkers. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  C-reactive protein; Carnitine; Inflammatory markers; Meta-analysis; Oxidative stress

Year:  2020        PMID: 33520867      PMCID: PMC7843735          DOI: 10.1007/s40200-020-00627-9

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  63 in total

1.  Colchicine modulates oxidative stress in serum and neutrophil of patients with Behçet disease through regulation of Ca²⁺ release and antioxidant system.

Authors:  Selma Korkmaz; Ijlal Erturan; Mustafa Nazıroğlu; Abdulhadi Cihangir Uğuz; Bilal Ciğ; Ishak Suat Övey
Journal:  J Membr Biol       Date:  2011-11-04       Impact factor: 1.843

2.  Effects of L-carnitine on oxidative stress responses in patients with renal disease.

Authors:  Ioannis G Fatouros; Ioannis Douroudos; Stylianos Panagoutsos; Ploumis Pasadakis; Michalis G Nikolaidis; Athanasios Chatzinikolaou; Apostolos Sovatzidis; Yiannis Michailidis; Athanasios Z Jamurtas; Dimitrios Mandalidis; Kyriakos Taxildaris; Vassilios Vargemezis
Journal:  Med Sci Sports Exerc       Date:  2010-10       Impact factor: 5.411

3.  L-Carnitine supplementation improved clinical status without changing oxidative stress and lipid profile in women with knee osteoarthritis.

Authors:  Aida Malek Mahdavi; Reza Mahdavi; Sousan Kolahi; Maryam Zemestani; Amir-Mansour Vatankhah
Journal:  Nutr Res       Date:  2015-06-16       Impact factor: 3.315

4.  Glycine propionyl-L-carnitine modulates lipid peroxidation and nitric oxide in human subjects.

Authors:  Richard J Bloomer; Lesley C Tschume; Webb A Smith
Journal:  Int J Vitam Nutr Res       Date:  2009-05       Impact factor: 1.784

5.  A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life.

Authors:  Antonio Macciò; Clelia Madeddu; Giulia Gramignano; Carlo Mulas; Carlo Floris; Eleonora Sanna; Maria Chiara Cau; Filomena Panzone; Giovanni Mantovani
Journal:  Gynecol Oncol       Date:  2011-12-20       Impact factor: 5.482

6.  The effect of L-carnitine treatment on levels of malondialdehyde and glutathione in patients with age related macular degeneration.

Authors:  Orhan Ates; H Hakan Alp; Ugur Mumcu; Sedat Azizi; Emine Cinici; Ahmet Kiziltunc; Orhan Baykal
Journal:  Eurasian J Med       Date:  2008-04

7.  Multiple dietary supplements do not affect metabolic and cardio-vascular health.

Authors:  Andreea Soare; Edward P Weiss; John O Holloszy; Luigi Fontana
Journal:  Aging (Albany NY)       Date:  2014-02       Impact factor: 5.682

8.  Effects of Carnitine Administration on Carotid Intima-media Thickness and Inflammatory Factors in Patients with Polycystic Ovary Syndrome: A Randomized, Double-blind, Placebo-controlled Trial.

Authors:  Hamid Reza Talari; Zeinab Jafari Azad; Yaser Hamidian; Mansooreh Samimi; Hamid Reza Gilasi; Faraneh Ebrahimi Afshar; Vahidreza Ostadmohammadi; Zatollah Asemi
Journal:  Int J Prev Med       Date:  2019-06-07

Review 9.  Inflammation in atherosclerotic cardiovascular disease.

Authors:  Prediman K Shah; Dalgisio Lecis
Journal:  F1000Res       Date:  2019-08-09

10.  Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: a randomized, placebo-controlled trial.

Authors:  Bor-Jen Lee; Jun-Shuo Lin; Yi-Chin Lin; Ping-Ting Lin
Journal:  Nutr J       Date:  2014-08-04       Impact factor: 3.271

View more
  8 in total

1.  Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study.

Authors:  Stacey N Reinke; Shama Naz; Romanas Chaleckis; Hector Gallart-Ayala; Johan Kolmert; Nazanin Z Kermani; Angelica Tiotiu; David I Broadhurst; Anders Lundqvist; Henric Olsson; Marika Ström; Åsa M Wheelock; Cristina Gómez; Magnus Ericsson; Ana R Sousa; John H Riley; Stewart Bates; James Scholfield; Matthew Loza; Frédéric Baribaud; Per S Bakke; Massimo Caruso; Pascal Chanez; Stephen J Fowler; Thomas Geiser; Peter Howarth; Ildikó Horváth; Norbert Krug; Paolo Montuschi; Annelie Behndig; Florian Singer; Jacek Musial; Dominick E Shaw; Barbro Dahlén; Sile Hu; Jessica Lasky-Su; Peter J Sterk; Kian Fan Chung; Ratko Djukanovic; Sven-Erik Dahlén; Ian M Adcock; Craig E Wheelock
Journal:  Eur Respir J       Date:  2022-06-30       Impact factor: 33.795

2.  The effects of L-carnitine on renal function and gene expression of caspase-9 and Bcl-2 in monosodium glutamate-induced rats.

Authors:  Farhad Koohpeyma; Morvarid Siri; Shaghayegh Allahyari; Marzieh Mahmoodi; Forough Saki; Sanaz Dastghaib
Journal:  BMC Nephrol       Date:  2021-05-02       Impact factor: 2.388

3.  L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection.

Authors:  Aouatef Bellamine; Tram N Q Pham; Jaspreet Jain; Jacob Wilson; Kazim Sahin; Frederic Dallaire; Nabil G Seidah; Shane Durkee; Katarina Radošević; Éric A Cohen
Journal:  Nutrients       Date:  2021-04-14       Impact factor: 5.717

4.  The effects of L-carnitine supplementation on inflammatory factors, oxidative stress, and clinical outcomes in patients with sepsis admitted to the intensive care unit (ICU): study protocol for a double blind, randomized, placebo-controlled clinical trial.

Authors:  Mahdi Keshani; Babak Alikiaii; Gholamreza Askari; Farveh Yahyapoor; Gordon A Ferns; Mohammad Bagherniya
Journal:  Trials       Date:  2022-02-22       Impact factor: 2.279

5.  Development and validation of an UHPLC-Orbitrap-HRMS method for rapid determination of endogenous L-carnitine in patients on hemodialysis/peritoneal dialysis and its application to promote rational drug use.

Authors:  Wen-Ting Jiang; Liu-Xing Tang; Jie Pan; Cun-Jin Su; Zhu Shen; Zhan-Hong Hu; Zhou-Bing Zhan; Ai-Ming Shi
Journal:  Ann Transl Med       Date:  2022-01

6.  Large-scale genetic correlation scanning and causal association between deep vein thrombosis and human blood metabolites.

Authors:  Pan Luo; Jiawen Xu; Shiqiang Cheng; Ke Xu; Wensen Jing; Feng Zhang; Peng Xu
Journal:  Sci Rep       Date:  2022-05-12       Impact factor: 4.996

7.  Effects of L-carnitine supplementation in patients with mild-to-moderate COVID-19 disease: a pilot study.

Authors:  Seyed Saman Talebi; Mehran Ghasemi; Maryam Etminani-Esfahani; Younes Mohammadi; Rasool Haddadi
Journal:  Pharmacol Rep       Date:  2022-08-23       Impact factor: 3.919

8.  Noopept Attenuates Diabetes-Mediated Neuropathic Pain and Oxidative Hippocampal Neurotoxicity via Inhibition of TRPV1 Channel in Rats.

Authors:  Halil Düzova; Mustafa Nazıroğlu; Bilal Çiğ; Perihan Gürbüz; Ayşe Nur Akatlı
Journal:  Mol Neurobiol       Date:  2021-07-09       Impact factor: 5.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.